DMCC reports revenue surge, PAT growth in Q4 FY26
DMCC Speciality Chemicals filed its Q4 FY26 earnings call transcript, reporting a PAT of ₹7.65 Cr, up 18.27% YoY, and revenue of ₹177.64 Cr, up 41.87% YoY. For FY26, PAT grew 26.95% to ₹27.33 Cr, and revenue rose 34.84% to ₹581.58 Cr. The board recommended a final dividend of ₹2.50 per share.

*this image is generated using AI for illustrative purposes only.
DMCC Speciality Chemicals Limited has filed the transcript of its earnings conference call held on Tuesday, May 19, 2026, regarding the financial performance of Q4 FY26. The filing was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript is accessible via the company's official website.
Earlier, the company announced its audited financial results for the quarter and full year ended March 31, 2026. For Q4, the company reported a Profit After Tax (PAT) of ₹7.65 Cr, rising 18.27% year-on-year from ₹6.47 Cr. Revenue from operations stood at ₹177.64 Cr, surging 41.87% YoY from ₹125.22 Cr. The Board of Directors recommended a final dividend of 25% (₹2.50 per equity share of ₹10 each) for FY26, subject to shareholder approval.
Q4 Financial Highlights
The company delivered broad-based growth across key metrics in Q4. EBITDA rose 14.73% YoY to ₹17.86 Cr, while EBITDA margins stood at 10.05%. Profit Before Tax grew 15.79% YoY to ₹10.81 Cr. Basic and Diluted EPS for Q4 stood at ₹3.07.
| Metric: | Q4 FY26 | Q4 FY25 | YoY Change |
|---|---|---|---|
| Revenue from Operations | ₹177.64 Cr | ₹125.22 Cr | +41.87% |
| Total Income | ₹177.80 Cr | ₹125.66 Cr | +41.50% |
| EBITDA | ₹17.86 Cr | ₹15.57 Cr | +14.73% |
| Profit After Tax | ₹7.65 Cr | ₹6.47 Cr | +18.27% |
| Basic & Diluted EPS (₹) | 3.07 | 2.59 | — |
Full Year FY26 Performance
For the full year FY26, PAT grew 26.95% to ₹27.33 Cr from ₹21.53 Cr in FY25. Annual revenue from operations rose 34.84% to ₹581.58 Cr. Annual EBITDA rose 10.23% to ₹64.33 Cr, while EBITDA margins contracted 245 basis points to 11.04%.
| Metric: | FY26 | FY25 | YoY Change |
|---|---|---|---|
| Revenue from Operations | ₹581.58 Cr | ₹431.30 Cr | +34.84% |
| Total Income | ₹582.61 Cr | ₹432.64 Cr | +34.66% |
| EBITDA | ₹64.33 Cr | ₹58.36 Cr | +10.23% |
| Profit After Tax | ₹27.33 Cr | ₹21.53 Cr | +26.95% |
Management Commentary
During the earnings call, Managing Director and CEO Mr. Bimal Goculdas highlighted that the Middle East crisis significantly impacted sulfur availability and pricing, with about 50% of global sulfur trade flowing through the Strait of Hormuz. Consequently, the Roha plant operated at reduced capacity (approximately 60%) for around 15 days in March to manage raw material shortages, while the Dahej plant operated normally using domestic sourcing.
Regarding the boron chemicals business, the first half of the year saw production losses due to supply disruption from Turkey, but operations resumed at full capacity in the second half. The company has also replaced most of its reduced European business with orders from Latin America and is developing markets in Japan, Korea, and China.
Corporate Developments
The board recommended a final dividend of ₹2.50 per share for FY26. The company's 105th Annual General Meeting is scheduled for Friday, September 11, 2026, via Video Conferencing. Additionally, the board appointed Shri S. S. Dongare as Cost Auditor for FY27.
Historical Stock Returns for DMCC Speciality Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.30% | -4.00% | -23.58% | -7.69% | -11.16% | -19.99% |
How will the company mitigate future supply chain disruptions given the volatility in sulfur availability and pricing?
What strategies are in place to sustain margin expansion as the company shifts focus to emerging markets like Latin America, Japan, and China?
Are there plans to increase domestic sourcing for the Roha plant to reduce dependency on global sulfur trade routes?


































